Mast cell stabilizers for treatment of hypercytokinemia and viral infection
AssigneeEmergo Therapeutics, Inc.
InventorsRobin Parish Hyde-DeRuyscher, Nancy Harlan Hyde-DeRuyscher, Elicia Kristine Hyde-DeRuyscher
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating hypercytokinemia and viral infections associated with hypercytokinemia using a mast cell stabilizing compound, optionally in combination with an antiviral agent. The invention further relates to compositions and dosage forms comprising mast cell stabilizing agents, optionally with an antiviral agent.
Claims14
A method of treating or ameliorating hypercytokinemia in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of norketotifen or a pharmaceutically acceptable salt thereof, thereby treating or ameliorating the hypercytokinemia, wherein the hypercytokinemia is caused by an influenza virus infection or an influenza-like illness.
A method of treating or ameliorating an influenza virus or an influenza-like illness associated with hypercytokinemia in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of norketotifen or a pharmaceutically acceptable salt thereof, thereby treating or ameliorating the influenza virus infection or influenza-like illness associated with hypercytokinemia.
Dependencies are inferred from the claim text.